Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The effect of nitric oxide synthase inhibition on β2-adrenoceptor mediated vasodilatation in the forearm arterial vasculature was determined. Forearm blood flow responses to intra-arterial infusions of ritodrine (2.5-50 μg/min) and serotonin (6-60 μg/min) with co-infusion of L-NMMA (800 μg/min) or noradrenaline (NAdr) (5-30 ng/min) were determined in 19 healthy young subjects (18-35 yrs), on 2 separate occasions, one week apart. Constriction (% ±SEM) to L-NMMA and NAdr was similar; 27±3 vs 26±3%, P=0.73. Maximal dilatation (%±SEM) to ritodrine was reduced during L-NMMA infusion compared to NAdr; 350 ±40 vs 244±32%, P<0.05. Mean AUC responses were 1043 ±134 vs 794±106, P=0.15. Vasodilator responses to serotonin were reduced to a greater extent during L-NMMA infusion; 115±18 vs 47±19%, P<0.03. β2-adrenergic mediated vasodilatation is partially NO mediated in human arterial vasculature.


Journal article


Clinical Pharmacology and Therapeutics

Publication Date